Results 1 to 10 of about 36,287 (271)

Calcitonin Gene-Related Peptide (CGRP) in Cerebrovascular Disease

open access: yesThe Scientific World Journal, 2002
Cerebral blood vessels are innervated by sensory nerves that store several neurotransmitters among which calcitonin gene-related peptide (CGRP) is the most abundant. In primary headaches, there is a clear association between the head pain and the release
Lars Edvinsson
doaj   +2 more sources

Overview of Calcitonin Gene-Related Peptide and Its Receptor [PDF]

open access: yesThe Scientific World Journal, 2001
Calcitonin Gene-Related Peptide (CGRP), a 37 amino acid peptide identified as the alternately spliced gene product of calcitonin gene, is a sensory neuropeptide with potent cardiovascular effects. CGRP is distributed throughout the central and peripheral
Nambi Aiyar
doaj   +2 more sources

Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine

open access: yesMolecular Pain, 2016
Background On trigeminal ganglion neurons, pain-sensing P2X3 receptors are constitutively inhibited by brain natriuretic peptide via its natriuretic peptide receptor-A. This inhibition is associated with increased P2X3 serine phosphorylation and receptor
Anna Marchenkova PhD   +4 more
doaj   +1 more source

Voluntary Forelimbs Exercise Reduces Immobilization-Induced Mechanical Hyperalgesia in the Rat Hind Paw

open access: yesPain Research and Management, 2021
Voluntary exercise is sufficient to protect against neuropathic pain. However, it is unclear whether voluntary exercise reduces immobilization-induced hyperalgesia. We examined the effect of voluntary forelimb exercise on immobilized-induced hyperalgesia
Kumiko Ishikawa   +7 more
doaj   +1 more source

Effects of Calcitonin-Gene-Related-Peptide on Auditory Nerve Activity

open access: yesFrontiers in Cell and Developmental Biology, 2021
Calcitonin-gene-related peptide (CGRP) is a lateral olivocochlear (LOC) efferent neurotransmitter. Depression of sound-driven auditory brainstem response amplitude in CGRP-null mice suggests the potential for endogenous CGRP release to upregulate ...
Colleen G. Le Prell   +4 more
doaj   +1 more source

Treating Menière’s disease with rimegepant

open access: yesSwiss Medical Weekly
A recent hypothesis states that Menière’s disease is caused by inappropriate expression, i.e. enhanced release of the neurotransmitter calcitonin gene-related peptide.
Stefan C. A. Hegemann, Angela Schell
doaj   +1 more source

Reducing Episodic Cluster Headaches: Focus on Galcanezumab

open access: yesJournal of Pain Research, 2020
Lanfranco Pellesi,1 Roberto De Icco,2,3 Mohammad Al-Mahdi Al-Karagholi,1 Messoud Ashina1,4 1Danish Headache Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2Headache Science Center, IRCCS Mondino Foundation,
Pellesi L   +3 more
doaj  

Research Progress in Calcitonin Gene-Related Peptide and Bone Repair

open access: yesBiomolecules, 2023
Calcitonin gene-related peptide (CGRP) has 37 amino acids. Initially, CGRP had vasodilatory and nociceptive effects. As research progressed, evidence revealed that the peripheral nervous system is closely associated with bone metabolism, osteogenesis ...
Qichang Wang   +6 more
doaj   +1 more source

Calcitonin Gene-Related Peptide in Tension-Type Headache

open access: yesThe Scientific World Journal, 2002
In the last 10 years there has been increasing interest in the role of calcitonin gene-related peptide (CGRP) in primary headaches. Tension-type headache is one of the most common and important types of primary headaches, and ongoing nociception from ...
M. Ashina
doaj   +1 more source

Calcitonin gene-related peptide: an update on the biology [PDF]

open access: yesCurrent Opinion in Neurology, 2009
This review includes the most relevant and recent studies on the biology of calcitonin gene-related peptide (CGRP) as it pertains to primary headaches and particularly to migraine. Especial attention was given to those published within the last year.The development of CGRP receptor antagonists is discussed in detail, as well as recent advances in our ...
Ana, Recober, Andrew F, Russo
openaire   +2 more sources

Home - About - Disclaimer - Privacy